F
Francis Berenbaum
Researcher at University of Paris
Publications - 17
Citations - 828
Francis Berenbaum is an academic researcher from University of Paris. The author has contributed to research in topics: Placebo & WOMAC. The author has an hindex of 10, co-authored 17 publications receiving 562 citations. Previous affiliations of Francis Berenbaum include French Institute of Health and Medical Research & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Metabolic stress-induced joint inflammation and osteoarthritis.
TL;DR: In this paper, a review discusses hypotheses based on pathways specific to a metabolic factor in MetS-associated OA, such as the role of advanced glycation end products and glucose toxicity.
Journal ArticleDOI
Modern-day environmental factors in the pathogenesis of osteoarthritis.
TL;DR: The possibility that OA is an evolutionary mismatch disease, which is a disease more common today than in the past because genes inherited from previous generations are inadequately or imperfectly adapted to modern environmental conditions, is reviewed.
Journal ArticleDOI
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
Francis Berenbaum,Francisco J. Blanco,Ali Guermazi,Kenji Miki,Takaharu Yamabe,Lars Viktrup,Rod Junor,William Carey,Mark T. Brown,Christine R. West,Kenneth M. Verburg +10 more
TL;DR: Tanezumab 5 mg statistically significantly improved pain, physical function and PGA-OA, but tanezumsumab 2.5mg only achieved two co-primary end points, but there was a statistically significant improvement in WOMAC Pain and Physical Function, but not PGA -OA.
Journal ArticleDOI
Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis
Marie-Charlotte Laiguillon,Alice Courties,Xavier Houard,Martine Auclair,Alain Sautet,Jacqueline Capeau,Bruno Fève,Francis Berenbaum,Jérémie Sellam +8 more
TL;DR: High glucose enhanced IL-1β-induced inflammation in cultured chondrocytes via oxidative stress and the polyol pathway may participate in the increased inflammation in OA.
Journal ArticleDOI
Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review.
TL;DR: Owing to the increasing RMD patients’ willingness to use mHealth apps for self-management, optimal standards and quality assurance of new apps are mandatory.